Ken Griffin
SBIO icon

Ken Griffin’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Ken Griffin’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$925K Buy
17,680
+8,702
+97% +$443K ﹤0.01% 7833
2025
Q4 		$460K Buy
+8,978
New +$415K ﹤0.01% 9230
2025
Q3 		– Sell
-23,706
Closed -$713K – 13935
2025
Q2 		$713K Buy
23,706
+9,154
+63% +$262K ﹤0.01% 7800
2025
Q1 		$415K Sell
14,552
-437
-3% -$13.8K ﹤0.01% 8887
2024
Q4 		$495K Buy
+14,989
New +$566K ﹤0.01% 8574
2024
Q3 		– Sell
-11,003
Closed -$370K – 15116
2024
Q2 		$370K Sell
11,003
-951
-8% -$31.9K ﹤0.01% 8693
2024
Q1 		$427K Sell
11,954
-6,758
-36% -$234K ﹤0.01% 8727
2023
Q4 		$616K Sell
18,712
-9,869
-35% -$265K ﹤0.01% 7645
2023
Q3 		$778K Buy
28,581
+19,264
+207% +$580K ﹤0.01% 7104
2023
Q2 		$294K Buy
9,317
+4,675
+101% +$145K ﹤0.01% 9094
2023
Q1 		$126K Sell
4,642
-22,244
-83% -$672K ﹤0.01% 10918
2022
Q4 		$817K Buy
26,886
+17,270
+180% +$520K ﹤0.01% 7204
2022
Q3 		$290K Buy
+9,616
New +$304K ﹤0.01% 9653
2022
Q2 		– Sell
-8,155
Closed -$274K – 13950
2022
Q1 		$274K Sell
8,155
-13,180
-62% -$457K ﹤0.01% 10791
2021
Q4 		$901K Buy
21,335
+1,218
+6% +$54.3K ﹤0.01% 8212
2021
Q3 		$916K Sell
20,117
-25,368
-56% -$1.16M ﹤0.01% 8378
2021
Q2 		$2.23M Buy
45,485
+31,632
+228% +$1.52M ﹤0.01% 6327
2021
Q1 		$696K Sell
13,853
-21,051
-60% -$1.17M ﹤0.01% 8955
2020
Q4 		$1.79M Sell
34,904
-7,186
-17% -$342K ﹤0.01% 5574
2020
Q3 		$1.73M Buy
42,090
+36,821
+699% +$1.52M ﹤0.01% 5001
2020
Q2 		$220K Buy
+5,269
New +$208K ﹤0.01% 8390
2020
Q1 		– Sell
-18,625
Closed -$712K – 10083
2019
Q4 		$787K Sell
18,625
-12,234
-40% -$454K ﹤0.01% 6031
2019
Q3 		$974K Buy
30,859
+7,855
+34% +$276K ﹤0.01% 5644
2019
Q2 		$831K Sell
23,004
-3,996
-15% -$138K ﹤0.01% 6000
2019
Q1 		$977K Sell
27,000
-84,689
-76% -$2.83M ﹤0.01% 5629
2018
Q4 		$3.14M Buy
111,689
+102,740
+1,148% +$3.41M ﹤0.01% 3448
2018
Q3 		$352K Sell
8,949
-19,337
-68% -$733K ﹤0.01% 7320
2018
Q2 		$1.05M Buy
28,286
+17,690
+167% +$642K ﹤0.01% 5129
2018
Q1 		$363K Buy
+10,596
New +$371K ﹤0.01% 6435
2017
Q2 		– Sell
-36,239
Closed -$934K – 7990
2017
Q1 		$934K Sell
36,239
-27,796
-43% -$692K ﹤0.01% 4107
2016
Q4 		$1.47M Buy
+64,035
New +$1.53M ﹤0.01% 3327
2016
Q2 		– Sell
-14,800
Closed -$324K – 7325
2016
Q1 		$324K Sell
14,800
-38,283
-72% -$875K ﹤0.01% 5002
2015
Q4 		$1.69M Sell
53,083
-37,915
-42% -$1.16M ﹤0.01% 2933
2015
Q3 		$2.54M Buy
+90,998
New +$3.18M ﹤0.01% 2657

Other funds holding SBIO

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
MWM
Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return

Ken Griffin's SBIO Position: Q1 2026 in Review

Ken Griffin increased its ALPS Medical Breakthroughs ETF (SBIO) stake by 97% in Q1 2026, buying an estimated $443K and bringing the position to 17,680 shares worth $925K. The position accounts for ﹤0.01% of the portfolio, ranked #7833.

Ken Griffin first reported a position in SBIO in Q3 2015 and has held it in 34 quarters since. The position peaked at $3.14M in Q4 2018. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

  • Ken Griffin held 17,680 shares of ALPS Medical Breakthroughs ETF worth $925K as of Q1 2026.
  • Ken Griffin bought 8,702 ALPS Medical Breakthroughs ETF shares in Q1 2026, an estimated $443K.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #7833 holding.
  • Ken Griffin first reported a position in ALPS Medical Breakthroughs ETF in Q3 2015 and has held it in 34 quarters since.
  • Ken Griffin's ALPS Medical Breakthroughs ETF position peaked at $3.14M in Q4 2018.
  • 59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.